In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
- 31 March 2004
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 61 (3) , 181-187
- https://doi.org/10.1016/j.antiviral.2003.10.003
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase geneJournal of General Virology, 2000
- Acyclovir-resistant Varicella-Zoster virus: Phenotypic and genetic characterizationJournal of Medical Virology, 1998
- Differential Susceptibility of Several Drug-Resistant Strains of Herpes Simplex Virus Type 2 to Various Antiviral CompoundsAntiviral Chemistry and Chemotherapy, 1997
- Varicella-zoster virusClinical Microbiology Reviews, 1996
- Penciclovir-Resistance Mutations in the Herpes Simplex Virus DNA Polymerase GeneAntiviral Chemistry and Chemotherapy, 1995
- Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compoundsAntimicrobial Agents and Chemotherapy, 1995
- Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virusEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virusAntimicrobial Agents and Chemotherapy, 1992
- Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidinesAntiviral Research, 1987
- Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell cultureAntimicrobial Agents and Chemotherapy, 1987